6Candler PM,Dale RC. Three cases of center nervous system complications associated with Mycoplasma pneumoniae [J]. Pediatr Neurol, 2004,31 (2) : 133.
7Nagalingam NA, Adesiyon AA, Swanaton WH, at al. Prevalence of mycoplasma pneumoniae and chlamydia pneumoniae in pneumonia patients in four major hospital in Trinidad[J]. New Microbiol, 2004,27 (4) : 345.
8Principi N, Esposito S. Mycoplasma pneumoniae and chlamydia pneumoniae cause lower respiratory tract diease in paediatric patients[J]. Curr Opin Infect Dis, 2002,15:295.
9Sutherland ER,Brandirff JM, Martin RJ. A typical bacterial pneumonia and asthma rsthma risk[J]. J Asthma,2004,41(8):863.
5Romero RA, Ponce HC, Ciprian A, et al. Immunomodulatroy propertyes of Mycoplasma pulmonis I characterization of the immuneomodulatory activity [ J ]. Int Immunopharmacol, 2001,1 ( 9- 10) :1679-1688.
6Morozumi M, Iwata S, Hasegawa K, et al. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patientswith community-acquired pneumonia[ J]. Antimicrob Agents Chemother, 2008,52( I ) :34~, - 350.
7Zhou W,Lin F,Teng L,et al. Prevalence of herpes and respiratory viruses in induced sputum among hospitalized children with non-typical bacterial community-acquired pneumonia [J]. PLoS One, 2013,8( 11 ) : e79477-e79477.
8Bordon J, Aliberti S, Duvvuri P, et al. Early administration of the first antimicrobials should be considered a marker of optimal care of patients with community-acquired pneu- monia rather than a predictor of outcomes [J]. Int J Infect Dis ,2013,17(5) : e293-298.
9Huong PL,Hien PT,Lan NT,et al. First report on preva- lence and risk factors of severe atypical pneumonia in Vietnamese children aged 1-5 years [J]. BMC Public Health,2014, 14: 1304-1311.
10Chen K,Jia R,Li L,et al. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patterns associated with age and season [J]. BMC Public Health, 2015,15 : 113-118.
